New Frontiers in Selective Human MAO-B Inhibitors

作者: Simone Carradori , Romano Silvestri

DOI: 10.1021/JM501690R

关键词: Monoamine oxidase BMigrainePharmacologySchizophreniaPersonality disordersIsatinAnorexia nervosaDegenerative DisorderChemistryDementia

摘要: Accumulating evidence shows a relationship between the human MAO-B (hMAO-B) enzyme and neuropsychiatric/degenerative disorder, personality traits, type II alcoholism, borderline disorders, aggressiveness violence in crime, obsessive-compulsive depression, suicide, schizophrenia, anorexia nervosa, migraine, dementia, PD. Thus, represents an attractive target for treatment of number diseases. The discovery, development, therapeutic use drugs that inhibit are major challenges future therapy. Various compounds selectively this isoform have been discovered recently. These agents synthetic or natural products their analogues, including chalcones, pyrazoles, chromones, coumarins, xanthines, isatin derivatives, thiazolidindiones, (thiazol-2-yl)hydrazones, analogues marketed drugs. Despite considerable efforts understanding binding interaction with specific substrates inhibitors, structural ...

参考文章(121)
Benjamin Drukarch, Freek L van Muiswinkel, Drug treatment of parkinson's disease : Time for phase II Biochemical Pharmacology. ,vol. 59, pp. 1023- 1031 ,(2000) , 10.1016/S0006-2952(99)00340-8
Creed W. Abell, Sau-Wah Kwan, Molecular characterization of monoamine oxidases A and B Progress in Nucleic Acid Research and Molecular Biology. ,vol. 65, pp. 129- 132 ,(2000) , 10.1016/S0079-6603(00)65004-3
Mohammed Naseer Ahmed Khan, Takayoshi Suzuki, Naoki Miyata, An Overview of Phenylcyclopropylamine Derivatives: Biochemical and Biological Significance and Recent Developments Medicinal Research Reviews. ,vol. 33, pp. 873- 910 ,(2013) , 10.1002/MED.21269
Anél Petzer, Paul Grobler, Jacobus J. Bergh, Jacobus P. Petzer, Inhibition of monoamine oxidase by selected phenylalkylcaffeine analogues. Journal of Pharmacy and Pharmacology. ,vol. 66, pp. 677- 687 ,(2014) , 10.1111/JPHP.12193
Joanna S Fowler, Gene-Jack Wang, Jean Logan, Shan Xie, Nora D Volkow, Robert R MacGregor, David J Schlyer, Naomi Pappas, David L Alexoff, Clifford Patlak, Alfred P Wolf, Selective reduction of radiotracer trapping by deuterium substitution : comparison of carbon-11-L-deprenyl and carbon-11-deprenyl-D2 for MAO B mapping The Journal of Nuclear Medicine. ,vol. 36, pp. 1255- 1262 ,(1995)
Rakhee Krishna, Manal Ali, Ahmed A. Moustafa, Effects of combined MAO-B inhibitors and levodopa vs. monotherapy in Parkinson’s disease Frontiers in Aging Neuroscience. ,vol. 6, pp. 180- 180 ,(2014) , 10.3389/FNAGI.2014.00180
Maria Joao Matos, Dolores Viña, Carmen Picciau, Francisco Orallo, Lourdes Santana, Eugenio Uriarte, Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors. Bioorganic & Medicinal Chemistry Letters. ,vol. 19, pp. 5053- 5055 ,(2009) , 10.1016/J.BMCL.2009.07.039
Simone Carradori, Jacobus P Petzer, Novel monoamine oxidase inhibitors: a patent review (2012 - 2014). Expert Opinion on Therapeutic Patents. ,vol. 25, pp. 91- 110 ,(2015) , 10.1517/13543776.2014.982535
C. Binda, F. Hubalek, M. Li, N. Castagnoli, D. E. Edmondson, A. Mattevi, Structure of the human mitochondrial monoamine oxidase B: new chemical implications for neuroprotectant drug design. Neurology. ,vol. 67, ,(2006) , 10.1212/WNL.67.7_SUPPL_2.S5
Franco Chimenti, Simone Carradori, Daniela Secci, Adriana Bolasco, Bruna Bizzarri, Paola Chimenti, Arianna Granese, Matilde Yáñez, Francisco Orallo, Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives. European Journal of Medicinal Chemistry. ,vol. 45, pp. 800- 804 ,(2010) , 10.1016/J.EJMECH.2009.11.003